We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.57B
AUM Growth
-$99.9M
(-6%)
Cap. Flow
-$270M
Cap. Flow
% of AUM
-17.18%
Top 10 Holdings %
Top 10 Hldgs %
52.85%
Holding
344
New
45
Increased
88
Reduced
69
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BZUN
Baozun
BZUN
|
+$17.1M |
| 2 |
MOMO
Hello Group
MOMO
|
+$5.31M |
| 3 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
+$4.25M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$4.13M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$3.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KANG
iKang Healthcare Group, Inc.
KANG
|
+$94.3M |
| 2 |
Vipshop
VIPS
|
+$47.3M |
| 3 |
DigitalBridge
DBRG
|
+$39.3M |
| 4 |
Brookdale Senior Living
BKD
|
+$37.8M |
| 5 |
Criteo
CRTO
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.62% |
| 2 | Financials | 6.46% |
| 3 | Consumer Discretionary | 4.13% |
| 4 | Industrials | 2.9% |
| 5 | Communication Services | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amneal Pharmaceuticals
AMRX
$5.59B
| $277M | 17.6% |
19,552,001
| – | – |
|
|
VRAY
2
DELISTED
ViewRay, Inc.
VRAY
| $122M | 7.73% |
16,471,258
| – | – |
|
|
SINA
3
DELISTED
Sina Corp
SINA
| $117M | 7.4% |
1,967,578
+35,802
| +2% | +$2.15M |
|
|
4
DigitalBridge
DBRG
$2.92B
| $51.3M | 3.26% |
2,410,461
-1,761,080
| -42% | -$39.3M |
|
|
BEST
5
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $33.2M | 2.11% |
331,701
| – | – |
|
6
Nature's Sunshine
NATR
$369M
| $26.5M | 1.68% |
2,854,607
| – | – |
|
7
Gilead Sciences
GILD
$165B
| $25.6M | 1.63% |
396,443
-53,718
| -12% | -$3.57M |
|
|
SFUN
8
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $21.8M | 1.39% |
323,617
+4,247
| +1% | +$325K |
|
|
9
Brookdale Senior Living
BKD
$3.57B
| $21.4M | 1.36% |
3,252,078
-5,151,306
| -61% | -$37.8M |
|
|
BZUN
10
Baozun
BZUN
$146M
| $20.3M | 1.29% |
+488,992
| New | +$17.1M |
|
|
SOHU
11
Sohu.com
SOHU
$346M
| $17.8M | 1.13% |
1,075,995
-85,455
| -7% | -$1.65M |
|
|
SDRL
12
DELISTED
Seadrill Limited Common Stock
SDRL
| $14.2M | 0.9% |
1,706,914
| – | – |
|
|
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
| $10.5M | 0.67% |
792,096
| – | – |
|
|
ARRY
14
DELISTED
Array Biopharma Inc
ARRY
| $9.12M | 0.58% |
384,055
-76,000
| -17% | -$1.58M |
|
|
SGEN
15
DELISTED
Seagen Inc. Common Stock
SGEN
| $8.73M | 0.55% |
121,605
-14,500
| -11% | -$1.03M |
|
|
16
Neurocrine Biosciences
NBIX
$17.4B
| $8.67M | 0.55% |
101,323
+39,000
| +63% | +$3.26M |
|
17
Verrica Pharmaceuticals
VRCA
$94.3M
| $8.59M | 0.55% |
79,428
| – | – |
|
18
BioMarin Pharmaceuticals
BMRN
$11.4B
| $8.57M | 0.54% |
97,650
+7,700
| +9% | +$714K |
|
|
19
Vipshop
VIPS
$7.01B
| $8.37M | 0.53% |
1,042,588
-6,671,894
| -86% | -$47.3M |
|
20
MakeMyTrip
MMYT
$5.05B
| $8.13M | 0.52% |
294,431
-323,822
| -52% | -$8.83M |
|
|
FOLD
21
DELISTED
Amicus Therapeutics
FOLD
| $7.82M | 0.5% |
581,969
+48,000
| +9% | +$586K |
|
22
Ascendis Pharma A/S
ASND
$16.5B
| $7.77M | 0.49% |
67,426
+14,100
| +26% | +$1.23M |
|
|
RVNC
23
DELISTED
Revance Therapeutics, Inc.
RVNC
| $7.45M | 0.47% |
472,532
| – | – |
|
24
Incyte
INCY
$23.1B
| $7.27M | 0.46% |
84,810
+8,200
| +11% | +$667K |
|
25
argenx
ARGX
$52.9B
| $6.69M | 0.42% |
53,705
+21,300
| +66% | +$2.5M |
|
Similar funds
NC
T2I
BA
IAA
PNFS
THL
LWPC
MHC
Fosun International's Q1 2019 Portfolio in Review
As of Q1 2019, Fosun International held 344 positions worth $1.57B, down 6% from $1.67B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Fosun International withdrew a net $270M in Q1 2019, closing 37 positions and reducing 69 holdings. Its most notable exit was iKang Healthcare Group, Inc., an estimated $94.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Fosun International opened a new position in Baozun worth $20.3M.
- Fosun International's largest Q1 2019 buy was Baozun: 488,992 shares worth $20.3M.
- Fosun International added most to Neurocrine Biosciences in Q1 2019, an estimated $3.26M increase.
- Fosun International's biggest Q1 2019 reduction was Vipshop, cutting an estimated $47.3M.
- Fosun International fully exited iKang Healthcare Group, Inc. in Q1 2019, selling an estimated $94.3M.
- Fosun International's ten largest holdings make up 53% of its $1.57B portfolio in Q1 2019.
- Fosun International opened 45 new positions and closed 37 in Q1 2019.
- Fosun International's portfolio value fell 6% quarter-over-quarter to $1.57B.
Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.